Betydning af inflammation for kvinders reproduktive sundhed

Low-grade systemic inflammation (LGSI) is increasingly recognised as a key factor in women's reproductive health. It has been associated with impaired fertility, pregnancy complications, and adverse health outcomes in the offspring. These associations highlight the potential of LGSI as a risk factor in the context of preconception preventive strategies and individualised risk assessment. However, before such applications can be implemented in clinical practice, further research is required to standardise biomarkers, define thresholds and establish whether targeted interventions can improve reproductive outcomes, as argued in this review.